DCAF7 and hepatocellular carcinoma: Altogether, these findings highlight that DCAF7 is elevated in HCC tissues, and its positive impact on HCC cell growth contributes to its oncogenic effect, underscoring the therapeutic potential of DCAF7 for HCC.